BioSig Technologies, Inc. announces a proposed public offering of shares of common stock (or pre-funded warrants) to purchase gold bullion and for general corporate purposes.
The joint book-running managers for the offering are Clear Street and Needham & Company, with the offering made under a shelf registration statement on Form S-3 declared effective by the SEC.
Interested parties should read the preliminary prospectus supplement and other relevant documents before investing in the offering.
Purpose of Offering
The net proceeds from the offering will be used to purchase gold bullion and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are serving as the joint book-running managers for the offering.
Regulatory Compliance
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
Information Availability
Interested parties can obtain copies of the prospectus supplement from the SEC's website or the offering managers.
Legal Disclaimer
This press release does not constitute an offer to sell or solicit to buy securities described herein.
- BioSig Technologies aims to enhance its investment policy by purchasing gold bullion through the offering.
- The use of joint book-running managers provides credibility and expertise to the offering process.
BioSig Technologies Inc.'s proposed public offering signals its strategic financial decisions and commitment to enhancing its investment policy.